Specifically in the context of obesity, GDF15 administration would be able to promote sympathetic activation and enhance thermogenesis in adipose tissues, aiding in weight management and metabolic regulation. This evidence concerns the gene GDF15 and obesity due to melanocortin 4 receptor deficiency.